Target intelligence / Profile preview

DnaJ heat shock protein family member C12 (DNAJC12)

Target
DNAJC12
Molecular classification
Co-chaperone, Protein folding regulator, Chaperone J-domain superfamily (Hsp40 family), Other
01

Overview

DNAJC12 is a member of the Hsp40 (DnaJ) family, acting as a co-chaperone protein that interacts with Hsp70 proteins to regulate the folding, assembly, and stability of client proteins[1][2][4]. Its primary known biological role is the stabilization and maintenance of aromatic amino acid hydroxylases, enzymes critical for neurotransmitter biosynthesis (including phenylalanine hydroxylase and tyrosine hydroxylase)[1][2][4]. Mutations in DNAJC12 can cause hyperphenylalaninemia and neurological disorders, including movement disorders and intellectual disability[2][4]. DNAJC12 also modulates proteostasis in selected cancer types, supporting cell proliferation and migration—possibly by intersecting with β-catenin and estrogen receptor signaling pathways in specific tumors[2]. Structurally, DNAJC12 contains a canonical J domain necessary for client protein recognition and binding, and the C-terminal region is critical for interaction with substrates like tyrosine hydroxylase[1]. DNAJC12’s function as a chaperone is ATP-independent for substrate stabilization but can have synergistic effects with Hsc/Hsp70 ATPase activity when in complex with specific clients[1].

Other names
DnaJ homolog subfamily C member 12JDP1J domain-containing protein 1HPANBH4DnaJ (Hsp40) homolog, subfamily C, member 12J domain protein 1dnaJ homolog subfamily C member 12
02

Biological functions

Protein foldingProtein stabilizationComplex assemblyExport of client proteinsProteostasis regulationMaintenance of neurotransmitter synthesis via aromatic amino acid hydroxylase stabilization
03

Disease associations

HyperphenylalaninemiaParkinsonismIntellectual disabilityMovement disordersCancer
04

Safety considerations

Potential neurological consequences (deficiency leads to neurotransmitter metabolic disturbances and movement disorders).Possible links to altered cancer cell behavior suggest safety considerations in modulating its activity in oncology settings.
05

Biomarkers

Mutations in DNAJC12 gene (for hyperphenylalaninemia diagnosis and related movement disorders)DNAJC12 expression levels (in select cancers for research/experimental biomarker use)

Beyond the preview

Go deeper on DnaJ heat shock protein family member C12 (DNAJC12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ heat shock protein family member C12 (DNAJC12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call